{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:03:03Z","timestamp":1740142983456,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Istanbul University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Acute tubulointerstitial nephritis (AIN) is an immune-mediated disorder that can cause acute kidney injury (AKI). We aimed to investigate the characteristics of patients with AIN and predictive factors for treatment response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Material and methods<\/jats:title>\n            <jats:p>In this study, thirty-one patients diagnosed with AIN on kidney biopsy between 2006 and 2021 were included. Baseline clinical, histopathological, and laboratory findings, including complete blood count (CBC), creatinine, erythrocyte sedimentation rate, C\u2011reactive protein, C3, C4, systemic immune inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and urinalysis were evaluated. Treatment response, mortality, and creatinine levels at the time of last follow-up were also noted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median age was 46 years and 80.6% were female. Median baseline creatinine and proteinuria levels were 4.1\u202fmg\/dL and 0.84\u202fgram\/day. The median follow-up period was 14\u00a0months and 93.5% received immunosuppressives. End-stage kidney disease (ESKD) developed in five patients (16.1%). Renal recovery (creatinine &lt;\u202f1.4\u202fmg\/dL) was observed in 17 patients (54.8%). Higher degrees of interstitial fibrosis, tubular atrophy, granuloma formation, global glomerulosclerosis, and higher baseline hemoglobin levels, in addition to a\u00a0longer interval between first symptom to initiation of immunosuppressives were associated with renal nonrecovery, statistically. Also, patients who progressed to ESKD had higher baseline hemoglobin (<jats:italic>p<\/jats:italic>\u202f=\u20090.033) and lymphocyte (<jats:italic>p<\/jats:italic>\u202f=\u20090.044) and lower PLR levels (<jats:italic>p<\/jats:italic>\u202f=\u20090.016), as well as higher degrees of global glomerulosclerosis (<jats:italic>p<\/jats:italic>\u202f=\u20090.014), interstitial fibrosis (<jats:italic>p<\/jats:italic>\u202f=\u20090.042), and tubular atrophy (<jats:italic>p<\/jats:italic>\u202f=\u20090.030).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Treatment response rates are low for AIN, which may lead to ESKD. Besides chronicity in histopathology specimens, higher baseline hemoglobin levels and lower platelet-to-lymphocyte ratio might be prognostic. Further studies should be conducted on new markers for AIN.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00508-024-02417-2","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T09:03:04Z","timestamp":1724749384000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Baseline systemic inflammatory indices and clinicopathological features to predict the outcome of acute tubulointerstitial nephritis"],"prefix":"10.1007","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2262-8627","authenticated-orcid":false,"given":"Ahmet Burak","family":"Dirim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazrin","family":"Namazova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve Guzel","family":"Dirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur Akin","family":"Oto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Serra","family":"Artan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Hurdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Ozluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"issue":"2","key":"2417_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000525561","volume":"147","author":"B Sanchez-Alamo","year":"2023","unstructured":"Sanchez-Alamo\u00a0B, Cases-Corona\u00a0C, Fernandez-Juarez\u00a0G. Facing the challenge of drug-induced acute interstitial. Nephritis Nephron. 2023;147(2):78\u201390. https:\/\/doi.org\/10.1159\/000525561.","journal-title":"Nephritis Nephron"},{"key":"2417_CR2","volume-title":"StatPearls","author":"RH Naik","year":"2023","unstructured":"Naik\u00a0RH, Annamaraju\u00a0P. Interstitial Nephritis. In: StatPearls. Treasure Island: StatPearls; 2023. 2023 Jan."},{"key":"2417_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02213-w","author":"K Szajek","year":"2021","unstructured":"Szajek\u00a0K, Kajdi\u00a0ME, Luyckx\u00a0VA, Fehr\u00a0TH, Gaspert\u00a0A, Cusini\u00a0A, Hohloch\u00a0K, Grosse\u00a0P. Granulomatous interstitial nephritis in a\u00a0patient with SARS-CoV\u20112 infection. BMC Nephrol. 2021; https:\/\/doi.org\/10.1186\/s12882-020-02213-w.","journal-title":"BMC Nephrol"},{"issue":"8","key":"2417_CR4","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.34067\/KID.0006642021","volume":"3","author":"A Donati","year":"2022","unstructured":"Donati\u00a0A, Krishnan\u00a0N. Should corticosteroids be used to treat biopsy-proven drug-induced acute interstitial nephritis?: PRO. Kidney. 2022;3(8):1306\u20139. https:\/\/doi.org\/10.34067\/KID.0006642021.","journal-title":"Kidney"},{"issue":"4","key":"2417_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3390\/jcm11041017","volume":"11","author":"TAP de Hond","year":"2022","unstructured":"de Hond\u00a0TAP, Ocak\u00a0G, Groeneweg\u00a0L, Oosterheert\u00a0JJ, Haitjema\u00a0S, Khairoun\u00a0M, Kaasjager\u00a0KAH. Hematological ratios are associated with acute kidney injury and mortality in patients that present with suspected infection at the emergency department. J\u00a0Clin Med. 2022;11(4):1017\u20131016. https:\/\/doi.org\/10.3390\/jcm11041017.","journal-title":"J Clin Med"},{"key":"2417_CR6","first-page":"1","volume":"3","author":"K Willis","year":"2012","unstructured":"Willis\u00a0K, Cheung\u00a0M, Slifer\u00a0SS, KDIGO board members. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Official J Int Soc Nephrol. 2012;3:1\u2013163.","journal-title":"Official J Int Soc Nephrol"},{"issue":"6","key":"2417_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00431-013-2030-7","volume":"172","author":"T Osumi","year":"2013","unstructured":"Osumi\u00a0T, Awazu\u00a0M, Fujimura\u00a0E, Yamazaki\u00a0F, Hashiguchi\u00a0A, Shimada\u00a0H. Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway. Eur J Pediatr. 2013;172(6):829\u201332. https:\/\/doi.org\/10.1007\/s00431-013-2030-7.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"2417_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/2277-9175.135417","volume":"26","author":"RA Bhat","year":"2014","unstructured":"Bhat\u00a0RA, Khan\u00a0I, Khan\u00a0I, Mir\u00a0MA. Polycythemia, increased erythropoietin levels in a\u00a0patient with renal lymphoma. Adv Biomed Res. 2014;26(3):147. https:\/\/doi.org\/10.4103\/2277-9175.135417.","journal-title":"Adv Biomed Res"},{"issue":"3","key":"2417_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.21470\/1678-9741-2017-0164","volume":"33","author":"H Parlar","year":"2018","unstructured":"Parlar\u00a0H, \u015ea\u015fk\u0131n\u00a0H. Are pre and postoperative platelet to lymphocyte ratio and neutrophil to lymphocyte ratio associated with early postoperative AKI following CABG? Braz J Cardiovasc Surg. 2018;33(3):233\u201341. https:\/\/doi.org\/10.21470\/1678-9741-2017-0164.","journal-title":"Braz J Cardiovasc Surg"},{"key":"2417_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1821-z","author":"CF Zheng","year":"2017","unstructured":"Zheng\u00a0CF, Liu\u00a0WY, Zeng\u00a0FF, Zheng\u00a0MH, Shi\u00a0HY, Zhou\u00a0Y, Pan\u00a0JY. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury. Crit Care. 2017; https:\/\/doi.org\/10.1186\/s13054-017-1821-z.","journal-title":"Crit Care"},{"issue":"10","key":"2417_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/ndt\/gfaa169","volume":"36","author":"DG Moledina","year":"2021","unstructured":"Moledina\u00a0DG, Wilson\u00a0FP, Kukova\u00a0L, Obeid\u00a0W, Luciano\u00a0R, Kuperman\u00a0M, Moeckel\u00a0GW, Kashgarian\u00a0M, Perazella\u00a0MA, Cantley\u00a0LG, Parikh\u00a0CR. Urine interleukin\u20119 and tumor necrosis factor\u2011\u03b1 for prognosis of human acute interstitial nephritis. Nephrol Dial Transplant. 2021;36(10):1851\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfaa169.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2417_CR12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1080\/0886022X.2021.1942914","volume":"43","author":"L Huang","year":"2021","unstructured":"Huang\u00a0L, Liang\u00a0S, Dong\u00a0J, Fan\u00a0W, Zeng\u00a0C, Zhang\u00a0T, Cheng\u00a0S, Ge\u00a0Y. Prognosis of severe drug-induced acute interstitial nephritis requiring renal replacement therapy. Ren Fail. 2021;43(1):1020\u20137. https:\/\/doi.org\/10.1080\/0886022X.2021.1942914.","journal-title":"Ren Fail"},{"issue":"2","key":"2417_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.nephro.2020.10.012","volume":"17","author":"S Hadded","year":"2021","unstructured":"Hadded\u00a0S, Harzallah\u00a0A, Chargui\u00a0S, Hajji\u00a0M, Kaaroud\u00a0H, Goucha\u00a0R, Ben Hamida\u00a0F, Gorsane\u00a0I, Ben Abdallah\u00a0T. \u00c9tiologies et facteurs pronostiques des n\u00e9phropathies interstitielles aigu\u00ebs. Nephrol Ther. 2021;17(2):114\u20139. https:\/\/doi.org\/10.1016\/j.nephro.2020.10.012. Etiologies and prognostic factors of acute interstitial nephritis.","journal-title":"Nephrol Ther"},{"issue":"13","key":"2417_CR14","doi-asserted-by":"publisher","first-page":"e168950","DOI":"10.1172\/JCI168950","volume":"133","author":"DG Moledina","year":"2023","unstructured":"Moledina\u00a0DG, Obeid\u00a0W, Smith\u00a0RN, Rosales\u00a0I, Sise\u00a0ME, Moeckel\u00a0G, Kashgarian\u00a0M, Kuperman\u00a0M, Campbell\u00a0KN, Lefferts\u00a0S, Meliambro\u00a0K, Bitzer\u00a0M, Perazella\u00a0MA, Luciano\u00a0RL, Pober\u00a0JS, Cantley\u00a0LG, Colvin\u00a0RB, Wilson\u00a0FP, Parikh\u00a0CR. Identification and validation of urinary CXCL9 as a\u00a0biomarker for diagnosis of acute interstitial nephritis. J\u00a0Clin Invest. 2023;133(13):e168950. https:\/\/doi.org\/10.1172\/JCI168950.","journal-title":"J Clin Invest"},{"issue":"10","key":"2417_CR15","doi-asserted-by":"publisher","first-page":"e127456","DOI":"10.1172\/jci.insight.127456","volume":"4","author":"DG Moledina","year":"2019","unstructured":"Moledina\u00a0DG, Wilson\u00a0FP, Pober\u00a0JS, Perazella\u00a0MA, Singh\u00a0N, Luciano\u00a0RL, Obeid\u00a0W, Lin\u00a0H, Kuperman\u00a0M, Moeckel\u00a0GW, Kashgarian\u00a0M, Cantley\u00a0LG, Parikh\u00a0CR. Urine TNF\u2011\u03b1 and IL\u20119 for clinical diagnosis of acute interstitial nephritis. JCI Insight. 2019;4(10):e127456. https:\/\/doi.org\/10.1172\/jci.insight.127456.","journal-title":"JCI Insight"},{"issue":"11","key":"2417_CR16","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","volume":"19","author":"MR Clarkson","year":"2004","unstructured":"Clarkson\u00a0MR, Giblin\u00a0L, O\u2019Connell\u00a0FP, O\u2019Kelly\u00a0P, Walshe\u00a0JJ, Conlon\u00a0P, O\u2019Meara\u00a0Y, Dormon\u00a0A, Campbell\u00a0E, Donohoe\u00a0J. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant. 2004;19(11):2778\u201383. https:\/\/doi.org\/10.1093\/ndt\/gfh485.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2417_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/1319-2442.252906","volume":"30","author":"M Surendra","year":"2019","unstructured":"Surendra\u00a0M, Raju\u00a0S, Chandragiri\u00a0S, Uppin\u00a0MS, Raju\u00a0N. Steroid therapy in drug induced acute interstitial nephritis\u2014Retrospective analysis of 83\u00a0cases. Saudi J Kidney Dis Transpl. 2019;30(1):157\u201365.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2417_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02372-4","author":"FH Mose","year":"2021","unstructured":"Mose\u00a0FH, Birn\u00a0H, Hoffmann-Petersen\u00a0N, Bech\u00a0JN. Prednisolone treatment in acute interstitial nephritis (PRAISE)\u2014protocol for the randomized controlled trial. BMC Nephrol. 2021; https:\/\/doi.org\/10.1186\/s12882-021-02372-4.","journal-title":"BMC Nephrol"},{"issue":"2","key":"2417_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ki.2014.294","volume":"87","author":"AK Muriithi","year":"2015","unstructured":"Muriithi\u00a0AK, Leung\u00a0N, Valeri\u00a0AM, Cornell\u00a0LD, Sethi\u00a0S, Fidler\u00a0ME, Nasr\u00a0SH. Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly. Kidney Int. 2015;87(2):458\u201364. https:\/\/doi.org\/10.1038\/ki.2014.294.","journal-title":"Kidney Int"},{"issue":"4","key":"2417_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","volume":"64","author":"AK Muriithi","year":"2014","unstructured":"Muriithi\u00a0AK, Leung\u00a0N, Valeri\u00a0AM, Cornell\u00a0LD, Sethi\u00a0S, Fidler\u00a0ME, Nasr\u00a0SH. Biopsy-proven acute interstitial nephritis, 1993\u20132011: a\u00a0case series. Am J Kidney Dis. 2014;64(4):558\u201366. https:\/\/doi.org\/10.1053\/j.ajkd.2014.04.027.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2417_CR21","first-page":"179","volume":"54","author":"A Schwarz","year":"2000","unstructured":"Schwarz\u00a0A, Krause\u00a0PH, Kunzendorf\u00a0U, Keller\u00a0F, Distler\u00a0A. The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol. 2000;54(3):179\u201390.","journal-title":"Clin Nephrol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-024-02417-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02417-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:02:28Z","timestamp":1737010948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-024-02417-2"}},"subtitle":["A\u00a0single-center retrospective study"],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2417"],"URL":"https:\/\/doi.org\/10.1007\/s00508-024-02417-2","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.B.\u00a0Dirim, N.\u00a0Namazova, M.G.\u00a0Dirim, O.A.\u00a0Oto, A.S.\u00a0Artan, O.\u00a0Hurdogan, Y.\u00a0Ozluk and H.\u00a0Yazici declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were carried out under the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration. This study was approved by Istanbul University Istanbul Faculty of Medicine Clinical Research Ethics Committee (decision date: 2021 and number: 172-05\/02\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}